Avid Bioservices 10K 2014 Annual report | CDMO Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: advice, allegedly, Betabody, Biothera, booked, Brazilian, Cal, canceled, candor, Cap, captionedAnderson, captionedMichaeli, captionedPeregrine, captionedRoy, carryforward, Chancery, Codification, contemporaneously, conversion, desperately, disallowance, dosimetry, encompassing, Evolution, flow, FMOx, grace, Imprime, improper, inviting, issuable, ix, judicial, Keystone, letter, mandatory, margin, master, maximize, melanoma, member, microenvironment, nonconsecutive, nonfinancial, nonrefundable, Overallotment, pembrolizumab, penalty, permanent, PGG, preceding, prejudice, preserve, ramucirumab, recover, redemption, RNBx, scenario, settle, SITC, strike, SUNRISE, supersede, takedown, thereof, TNCA, transition, treatable, underwriting, underwritten, uneven, unissued, unpaid, unpredictable, vi, vii, viii, Western

Removed: abundance, accredited, added, adjuvant, administered, advancement, advancing, AEs, afatinib, aggressive, aid, Alimta, alive, anaplastic, assistance, astrocytoma, attaching, augment, Avastin, awarded, bevacizumab, billable, binding, Boehringer, cabazitaxel, carmustine, castration, cavity, Celldex, Cetuximab, cisplatin, communication, compound, computer, conjugated, conventional, cord, CRO, cured, curetech, database, DCAA, DCVax, dead, decreased, degradation, departure, destroying, developmental, diagnosed, dissimilar, dying, effort, Eisai, enhanced, Erbitux, eventually, execute, exemption, explaining, exporting, falling, FDAMA, fever, float, front, gauge, gemcitabine, Gemzar, GlaxoSmithKline, Gliadel, glial, hemorrhagic, Herceptin, highest, implant, inclined, incorporate, independently, infringement, infusion, Ingelheim, inserted, interdealer, interior, interstitial, iodine, isotope, kill, kinase, largest, linked, localization, malignant, mandated, McNicoll, merger, mutually, Necrotic, neurologic, Nexavar, nontoxic, Northwest, Novocure, ocular, operated, oral, orally, orphan, ORR, OSI, OTC, OTCQX, Package, pancreatic, PCT, penny, peptide, Pfizer, PFS, point, polifeprosan, prevail, produced, profile, proportion, proportional, proportionate, prostate, protected, PTA, qualifying, quotation, radioisotope, radiolabeled, radiolabeling, reach, receptor, recognizing, regular, reinvest, remission, resection, resistant, resultant, resulted, Rituxan, rituximab, secrecy, slightly, Smith, sooner, spinal, sponsor, stimulated, subcontract, sued, suffered, suitability, supplier, supportive, surgical, Tarceva, Taxol, Taxotere, Temodar, temozolomide, thirty, thought, TMT, tolerated, train, trastuzumab, unconditionally, vaccine, Vlak, Wafer, wearable, Wm, world, Yervoy

Avid Bioservices (CDMO) 10-K2014 FY Annual report

Content analysis